These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 30033232)

  • 1. Improving Plasmodium vivax malaria treatment: a little more chloroquine.
    Snounou G
    Lancet Infect Dis; 2018 Sep; 18(9):934-935. PubMed ID: 30033232
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.
    Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM
    Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
    Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G
    Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primaquine for preventing relapses in people with Plasmodium vivax malaria.
    Galappaththy GN; Omari AA; Tharyan P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
    Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
    Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine sensitivity of Plasmodium vivax in Thailand.
    Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
    Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on Plasmodium vivax chloroquine resistance].
    Li JY; Li Q; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):326-31. PubMed ID: 25345166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced primaquine resistance in vivax malaria.
    ARNOLD J; ALVING AS; CLAYMAN CB
    Trans R Soc Trop Med Hyg; 1961 Jul; 55():345-50. PubMed ID: 13684386
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax remains responsive to chloroquine with primaquine treatment regimen: a prospective cohort study from tertiary care teaching hospital in southern India.
    Saravu K; Acharya V; Kumar K; Kumar R
    Trop Doct; 2012 Jul; 42(3):163-4. PubMed ID: 22516030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
    Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
    Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic failure wtih chloroquine and primaquine in malaria by Plasmodium vivax].
    Ocampo A; García-Bujalance S; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):490-1. PubMed ID: 9919001
    [No Abstract]   [Full Text] [Related]  

  • 20. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.